Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study
No grade 4 or 5 cases of cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome occurred.
Gabrielle Masson
May 31, 2025 7:00pm
HCW Biologics clings on with $5M lifeline to fund alopecia trial
May 16, 2025 7:00am
Allogene lays off 28% of staff to save cash amid program delays
May 14, 2025 8:00am
Kyverna lays off 16% as autoimmune CAR-T plans take shape
May 14, 2025 6:30am
Atara lays off more staff despite FDA lifting clinical hold
May 13, 2025 10:07am
Galapagos gets cold feet over plans to split up company
May 13, 2025 6:55am
